Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium
Open Access
- 1 January 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (1) , 161-167
- https://doi.org/10.1128/aac.48.1.161-167.2004
Abstract
Fluconazole (FLZ) has emerged as a highly successful agent in the management of systemic infections of Candida. Cure rates for symptomatic candidiasis following single 150-mg FLZ dose therapy exceed 90%. In vitro, however, FLZ is fungistatic only in a narrow pH range and is not effective at vaginal pH, 4.2. This study evaluated the effect of FLZ on Candida albicans under in vitro conditions resembling the vaginal microenvironment, using vagina-simulative medium (VS). We found that FLZ was fungicidal for C. albicans in VS, but not in other media at the same pH, 4.2. In VS, FLZ was fungicidal at concentrations of ≥8 μg/ml and reduced viability by greater than 99.9%. Analysis of the components of VS indicated that 17 mM acetic acid, a concentration achieved in the vagina, was responsible for the synergistic, fungicidal effect. This effect was not seen at neutral pH. Other substrates were not effective substitutes for acetic acid; however, short-chained carboxylic acids, glyoxylate and malonate, were effective. Most strains of C. albicans that were resistant to FLZ under standard conditions were killed by FLZ plus acetate. Other species of Candida were also killed, except C. krusei and C. glabrata. This study shows that FLZ has fungicidal activity for Candida species under in vitro conditions that mimic the vaginal microenvironment. This raises the possibility that FLZ may also have fungicidal effects during treatment of vaginal candidiasis. Elucidating the mechanism by which FLZ and acetate interact may disclose vulnerable pathways that could be exploited in drug development.Keywords
This publication has 62 references indexed in Scilit:
- Treatment of vaginal Candida infectionsExpert Opinion on Pharmacotherapy, 2002
- A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusionDiagnostic Microbiology and Infectious Disease, 2000
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- Success Rates and Cost‐Effectiveness of Antibiotic Combinations for Initial Treatment of Central‐Venous‐Line Infections During Total Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 2000
- Correlation of In Vitro Fluconazole Susceptibility with Clinical Outcome for Severely Ill Patients with Oropharyngeal CandidiasisClinical Infectious Diseases, 1998
- Analysis of fluconazole effect on Candida albicans viability during extended incubationsMedical Mycology, 1998
- Fluconazole susceptibility of Candida isolates from oropharyngeal candidosisMycoses, 1997
- Synergy of fluconazole with macrophages for antifungal activity againstCandida albicansMycopathologia, 1995
- Correlation between antifungal susceptibility testing ofCandida isolates from patients with HIV infection and clinical results after treatment with fluconazoleInfection, 1994
- Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993